Health insurer Humana raised its full-year 2026 profit forecast, now expecting adjusted earnings of at least $9.50 per share, up from at least $9.00 previously. The company pointed to continued control over medical expenses.
For the third quarter, its insurance-segment medical cost ratio came in at 93.7%, below the 94.39% analysts expected, according to LSEG data. Adjusted earnings were a loss of $0.70 per share, narrower than the $1.00 loss analysts had forecast.
The result matters because medical cost trends are the main swing factor for Medicare Advantage insurers, and Humana is signalling that costs are cooling.